General
Preferred name
LYPRESSIN
Synonyms
Lysine vasopressin acetate ()
[Lys8]-Vasopressin acetate ()
Lysipressin acetate(50-57-7(fb_acetate)) ()
Lysipressin ()
Lysipressin (acetate) ()
Lysine vasopressin ()
[Lys8]-Vasopressin ()
Lysine vasopressin (acetate) ()
[Lys8]-Vasopressin (acetate) ()
LVP ()
8-l-lysinevasopressin ()
L-8 ()
Diapid ()
Vasopressin, 8-l-lysine ()
Vasopressin pig ()
P&D ID
PD047067
CAS
50-57-7
83968-49-4
Tags
available
natural product
drug
Approved by
FDA
Drug Status
approved
Drug indication
Amnesia
Antidiuretic
Vasoconstrictor
Max Phase
Phase 4
First approval
1982
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
15
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
ReFrame library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
23
Properties
(calculated by RDKit )
Molecular Weight
1055.43
Hydrogen Bond Acceptors
16
Hydrogen Bond Donors
13
Rotatable Bonds
19
Ring Count
4
Aromatic Ring Count
2
cLogP
-4.33
TPSA
425.55
Fraction CSP3
0.5
Chiral centers
8.0
Largest ring
20.0
QED
0.05
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
AVPR1A, AVPR1B, AVPR2
Adenylate cyclase
Indication
central diabetes insipidus
MOA
Vasopressin Receptor agonist
Pathway
GPCR/G protein
Source data
